News

Filter

Current filters:

OtsukaAstraZeneca

Japanese approval for Forxiga and Lonsurf

24-03-2014

Anglo-Swedish drug major AstraZeneca says that Japanese Ministry of Health, Labor and Welfare approved…

Asia-PacificAstraZenecaDiabetesForxigaJapanLonsurfOncologyOno PharmaceuticalOtsukaPharmaceuticalRegulationTaiho Pharmaceutical

Resubmission of aripiprazole NDA accepted; AstraZeneca bond issue

12-09-2012

Danish CNS-focused drugmaker Lundbeck (LUND: DC) and Japanese partner Otsuka Pharmaceutical (TYO: 4668)…

aripiprazole depotAstraZenecaFinancialLundbeckNeurologicalNorth AmericaOtsukaPharmaceuticalRegulation

First-line use of Abilify more than doubles over past year for newly-diagnosed patients with bipolar disorder

19-11-2010

First-line use of Bristol Myers-Squibb(NYSE: BMY)/Otsuka's (TYO: 4523) Abilify (aripiprazole) has increased…

AbilifyAstraZenecaBristol-Myers SquibbMarkets & MarketingNeurologicalOtsukaPharmaceuticalSeroquel XR

COMPANY SPOTLIGHT

Menarini

Back to top